Garnett, Timothy John — Insider Profile

Insider Profile

Garnett, Timothy John

$CRDL

Companies Filed At

Open-Market Buys (2yr)

—

Buy Value (2yr, open-market)

Dec 30, 2025

Most Recent Trade

Credibility
Score

Hit Rate

-11.8%

Avg 90d Return

-11.8%

Median 90d Return

Evaluated Trades

-11.7%

Best Trade

-11.9%

Worst Trade

Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	15,594	—	—	45
Dec 03, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	60,000	$1.00	$60K	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	14,318	—	—	45
May 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	60,000	$1.16	$70K	45
May 28, 2025	$CRDL Cardiol Therapeutics Inc	—	Other	Sell	—	—	—	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.